{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:08:57Z","timestamp":1793225337938,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023447","name":"CHU Sainte-Justine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010978","name":"Wallonie-Bruxelles International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.autrev.2025.103824","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T18:49:53Z","timestamp":1745693393000},"page":"103824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity"],"prefix":"10.1016","volume":"24","author":[{"given":"Cl\u00e9ment","family":"Triaille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hadchouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Fr\u00e9mond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103824_bb0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fimmu.2020.00525","article-title":"Animal models of ANCA associated vasculitis","volume":"11","author":"Shochet","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.2010.198","article-title":"Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals","volume":"78","author":"Cui","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.autrev.2025.103824_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(24)00025-0","article-title":"Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Arnold","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2025.103824_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102579","article-title":"Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study","volume":"117","author":"Berglin","year":"2021","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2025.103824_bb0025","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.autrev.2025.103824_bb0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2025.103824_bb0035","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.40034","article-title":"Identification of functional and expression polymorphisms associated with risk for Antineutrophil cytoplasmic autoantibody-associated Vasculitis","volume":"69","author":"Merkel","year":"2017","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0040","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/rheumatology\/keab912","article-title":"Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA","volume":"61","author":"Dahlqvist","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"10427","key":"10.1016\/j.autrev.2025.103824_bb0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"issue":"SI2","key":"10.1016\/j.autrev.2025.103824_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead693","article-title":"Comparison of EULAR\/PRINTO\/PReS Ankara 2008 and 2022 ACR\/EULAR classification criteria for granulomatosis with polyangiitis in children","volume":"63","author":"Kaya Akca","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004315","article-title":"Predictive utility of ANCA positivity and antigen specificity in the assessment of kidney disease in paediatric-onset small vessel vasculitis","volume":"10","author":"Mann","year":"2024","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2025.103824_bb0065","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2215\/CJN.19181220","article-title":"Prognostic factors and long-term outcome with ANCA-associated kidney Vasculitis in childhood","volume":"16","author":"Calatroni","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0070","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00467-022-05855-0","article-title":"Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study","volume":"38","author":"Mahi","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2025.103824_bb0075","article-title":"Evaluating renal disease in pediatric-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: disease course, outcomes, and predictors of outcome","author":"Toor","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103824_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004481","article-title":"Course of paediatric ANCA-associated glomerulonephritis: advocating for an age-inclusive approach","volume":"10","author":"Barnini","year":"2024","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.autrev.2025.103824_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41584-022-00819-y","article-title":"Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management","volume":"18","author":"Trivioli","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/ndt\/gfac265","article-title":"ANCA-associated vasculitis in children","volume":"38","author":"Bernardi","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.autrev.2025.103824_bb0095","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/acr.24590","article-title":"Consensus treatment plans for severe pediatric Antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"74","author":"Morishita","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.autrev.2025.103824_bb0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated Vasculitis","volume":"384","author":"DRW","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0105","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1038\/s41467-018-07425-1","article-title":"STING-dependent sensing of self-DNA drives silica-induced lung inflammation","volume":"9","author":"Benmerzoug","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.autrev.2025.103824_bb0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa syndrome: a novel autosomal dominant immune Dysregulatory disease","volume":"36","author":"Vece","year":"2016","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.ajkd.2024.05.014","article-title":"Lupus nephritis patterns and response to type I interferon in patients with DNASE1L3 variants: report of three cases","volume":"84","author":"Volpi","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.autrev.2025.103824_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163604","article-title":"Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoin fl ammatory syndrome","volume":"134","author":"Delafontaine","year":"2024","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2025.103824_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10875-024-01717-6","article-title":"Functional validation of a COPA mutation broadens the spectrum of COPA syndrome","volume":"44","author":"Kechiche","year":"2024","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0135","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00017-2018","article-title":"Analysis of pulmonary features and treatment approaches in the COPA syndrome","volume":"4","author":"Tsui","year":"2018","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12969-019-0359-9","article-title":"An unprecedented COPA gene mutation in two patients in the same family: comparative clinical analysis of newly reported patients with other known COPA gene mutations","volume":"17","author":"Patwardhan","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.09.002","article-title":"COPA syndrome, 5 years after: where are we?","volume":"88","author":"Fremond","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0150","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ekir.2019.04.014","article-title":"COPA syndrome as a cause of lupus nephritis","volume":"4","author":"Boulisfane-El Khalifi","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2025.103824_bb0160","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients","volume":"9","author":"Fremond","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.autrev.2025.103824_bb0170","article-title":"Ocular complications of SAVI: a unique case of bilateral uveitis and retinal vasculitis","volume":"34","author":"Menean","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"4","key":"10.1016\/j.autrev.2025.103824_bb0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/pde.15559","article-title":"A case of STING-associated vasculopathy with onset in infancy with novel STING1 variant","volume":"41","author":"Barry","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.autrev.2025.103824_bb0180","article-title":"Case report: novel SAVI-causing variants in STING1 expand the clinical disease Spectrum and suggest a refined model of STING activation","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0185","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamadermatol.2015.0251","article-title":"Stimulator of interferon genes-associated vasculopathy with onset in infancy: a mimic of childhood granulomatosis with Polyangiitis","volume":"151","author":"Munoz","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2025.103824_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575219","article-title":"Adult-onset ANCA-associated Vasculitis in SAVI: extension of the phenotypic spectrum, case report and review of the literature","volume":"11","author":"Staels","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.autrev.2025.103824_bb0200","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2025.103824_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keae679","article-title":"A deep dive into monogenic lupus: insights on DNASE1L3 mutation","author":"Abdwani","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0210","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10875-022-01287-5","article-title":"DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling","volume":"42","author":"Tusseau","year":"2022","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0215","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaci.2018.04.030","article-title":"Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity","volume":"143","author":"Edwards","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103824_bb0220","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri.2016.93","article-title":"PI3Kdelta and primary immunodeficiencies","volume":"16","author":"Lucas","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103824_bb0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","article-title":"Activated PI3 Kinase Delta syndrome: from genetics to therapy","volume":"9","author":"Michalovich","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103824_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211013222","article-title":"Activated phosphoinositide 3-kinase delta syndrome misdiagnosed as anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report","volume":"49","author":"Zhang","year":"2021","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12969-024-00955-7","article-title":"Activated phosphoinositide 3-kinase delta syndrome caused by PIK3CD mutations: expanding the phenotype","volume":"22","author":"Zhao","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.autrev.2025.103824_bb0240","article-title":"Case report: activating PIK3CD mutation in patients presenting with granulomatosis with polyangiitis","volume":"12","author":"Lu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103824_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1179788","article-title":"ANCA vasculitis expands the spectrum of autoimmune manifestations of activated PI3 kinase delta syndrome","volume":"11","author":"Sood","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2025.103824_bb0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1750-1172-8-161","article-title":"New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare((R)) cohort","volume":"8","author":"Taytard","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13023-018-0806-6","article-title":"Pulmonary hemosiderosis in children with down syndrome: a national experience","volume":"13","author":"Alimi","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00860750","article-title":"Anti-neutrophil cytoplasmic antibody associated glomerulonephritis in a patient with down\u2019s syndrome","volume":"9","author":"Robson","year":"1995","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0265","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/ndt\/13.8.2142","article-title":"Proteinase-3-antineutrophil cytoplasmic antibody (PR3-ANCA) positive crescentic glomerulonephritis in a patient with down\u2019s syndrome and infectious endocarditis","volume":"13","author":"Haseyama","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00862096","article-title":"A patient with down\u2019s syndrome and anti-neutrophilic cytoplasmic antibody-positive vasculitis","volume":"10","author":"Schwab","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2025.103824_bb0275","first-page":"5","article-title":"Trisomy 21 consistently activates the interferon response","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.autrev.2025.103824_bb0280","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.coi.2021.06.006","article-title":"Down syndrome and type I interferon: not so simple","volume":"72","author":"Malle","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"26","key":"10.1016\/j.autrev.2025.103824_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg6218","article-title":"Multidimensional definition of the interferonopathy of down syndrome and its response to JAK inhibition","volume":"9","author":"Galbraith","year":"2023","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0290","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00205-2018","article-title":"Prolidase deficiency diagnosed by whole exome sequencing in a child with pulmonary capillaritis","volume":"5","author":"Rayment","year":"2019","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.autrev.2025.103824_bb0295","article-title":"VEXAS syndrome as a mimicker of ANCA-associated vasculitis","volume":"8","author":"Murillo-Chavez","year":"2024","journal-title":"Rheumatol Adv Pract"},{"issue":"5","key":"10.1016\/j.autrev.2025.103824_bb0300","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1097\/MJT.0000000000000323","article-title":"Successful treatment of ANCA-associated Vasculitis in the setting of common variable immunodeficiency using rituximab","volume":"23","author":"Hill","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.autrev.2025.103824_bb0305","doi-asserted-by":"crossref","unstructured":"Bulkhi AA, Fergeson JE, Glaum MC, Lockey RF. A case of common variable immunodeficiency (CVID) and antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis. J Allergy Clin Immunol n.d. 139(2, AB19).","DOI":"10.1016\/j.jaci.2016.12.016"},{"issue":"9190","key":"10.1016\/j.autrev.2025.103824_bb0310","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0140-6736(99)04206-3","article-title":"Association of a syndrome resembling Wegener\u2019s granulomatosis with low surface expression of HLA class-I molecules","volume":"354","author":"Moins-Teisserenc","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0315","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.autrev.2025.103824_bb0320","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103824_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021339","article-title":"Toll-like receptor 9 induced dendritic cell activation promotes anti-myeloperoxidase autoimmunity and glomerulonephritis","volume":"24","author":"Ford","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0330","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.autrev.2025.103824_bb0335","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220759","article-title":"Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS\/STING\/IFN-mediated nucleic acid sensing","volume":"219","author":"Kessler","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103824_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1072598","article-title":"The genomic landscape of ANCA-associated vasculitis: distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus","volume":"14","author":"Banos","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103824_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638571","article-title":"Different disease endotypes in phenotypically similar vasculitides affecting small-to-medium sized blood vessels","volume":"12","author":"Gill","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0350","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1038\/s41467-023-41328-0","article-title":"Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis","volume":"14","author":"Nishide","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103824_bb0355","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1038\/s41598-021-87760-4","article-title":"Investigation of type I interferon responses in ANCA-associated vasculitis","volume":"11","author":"Batten","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0360","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.27398","article-title":"Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener\u2019s granulomatosis","volume":"62","author":"Cheadle","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103824_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102617","article-title":"Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls","volume":"119","author":"Yanaoka","year":"2021","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0370","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2009.108043","article-title":"Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis","volume":"69","author":"Lyons","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2025.103824_bb0375","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.kint.2020.04.037","article-title":"ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation","volume":"98","author":"Jones","year":"2020","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.autrev.2025.103824_bb0380","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jmedgenet-2018-105560","article-title":"Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features","volume":"56","author":"Taveira-DaSilva","year":"2019","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.autrev.2025.103824_bb0385","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0961203316676382","article-title":"An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus","volume":"26","author":"Carbonella","year":"2017","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0390","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard-2022-223628","article-title":"2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice","volume":"82","author":"Rodriguez-Carrio","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2025.103824_bb0395","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.kint.2022.02.031","article-title":"Type I interferon-related kidney disorders","volume":"101","author":"Lodi","year":"2022","journal-title":"Kidney Int"},{"issue":"14","key":"10.1016\/j.autrev.2025.103824_bb0400","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177003","article-title":"A dual-acting DNASE1\/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models","volume":"9","author":"Stabach","year":"2024","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.autrev.2025.103824_bb0405","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2022018546","article-title":"A randomized, placebo-controlled phase 3 trial of the PI3Kdelta inhibitor leniolisib for activated PI3Kdelta syndrome","volume":"141","author":"Rao","year":"2023","journal-title":"Blood"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:06:55Z","timestamp":1749323215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1568997225000849"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103824","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103824"}}